PHILADELPHIA, Nov. 7, 2013 /PRNewswire via COMTEX/ -- Echo Therapeutics, Inc. /quotes/zigman/17757247/delayed/quotes/nls/ecte ECTE +3.20% , a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced its financial results for the quarter ended September 30, 2013. Echo’s Quarterly Report on Form 10-Q, when filed with the SEC, will be available by visiting the Investors section of Echo’s website at www.echotx.com.
Help employers find you! Check out all the jobs and post your resume.
